codes

NCIt: C46089

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

147 sites for NCT04293562

BCR-ABL1 Fusion, +48 more biomarkers

Acute Myeloid Leukemia

allogeneic hematopoietic stem cell transplantation, +12 more drugs

cellular therapy, +4 more types

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

109 sites for NCT01949129

Acute Lymphoblastic Leukemia

allogeneic hematopoietic stem cell transplantation, +7 more drugs

cellular therapy, +2 more types

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

105 sites for NCT04530565

ABL1 T315I, +2 more biomarkers

B-Cell Acute Lymphoblastic Leukemia

allogeneic hematopoietic stem cell transplantation, +10 more drugs

cellular therapy, +4 more types

Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

129 sites for NCT03126916

MYCN Amplification, +1 more biomarker

Ganglioneuroblastoma, +1 more condition

aldesleukin, +18 more drugs

cellular therapy, +4 more types

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

178 sites for NCT03007147

BCR-ABL1 Fusion, +1 more biomarker

Acute Lymphoblastic Leukemia

allogeneic hematopoietic stem cell transplantation, +18 more drugs

cellular therapy, +4 more types

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Acute Leukemia After T Cell Depleted Allo-HSCT

1 site for NCT04959903

ABL1 Fusion, +69 more biomarkers

Acute Lymphoblastic Leukemia, +1 more condition

allogeneic hematopoietic stem cell transplantation

cellular therapy